Related Experiment Video
Updated: Jun 20, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Dietary therapy for inflammatory rheumatic diseases]
1Ernährungsmedizin Physiologikum der Ludwig-Maximilians-Universität München, München. olaf.adam@lrz.uni-muenchen.de
Deutsche Medizinische Wochenschrift (1946)
|September 1, 2009
Summary
Individual dietary counseling is crucial for inflammatory rheumatic diseases, supporting pharmacotherapy and improving long-term outcomes. Nutritional therapy benefits emerge within three months, potentially reducing medication needs over a year.
Area of Science:
- Rheumatology
- Nutrition Science
- Pharmacology
Context:
- Inflammatory rheumatic diseases require comprehensive management strategies.
- Pharmacotherapy, including disease-modifying antirheumatic drugs (DMARDs), is a cornerstone of treatment.
- Nutritional status and dietary habits can significantly influence disease activity and patient outcomes.
Purpose:
- To highlight the importance of individualized dietary counseling for patients with inflammatory rheumatic diseases.
- To emphasize the synergistic role of nutritional therapy alongside pharmacotherapy.
- To outline the timeline and potential benefits of dietary interventions in managing rheumatic conditions.
Summary:
- Patients with inflammatory rheumatic diseases benefit from personalized dietary counseling tailored to their specific condition, intolerances, and comorbidities.
- Dietary education empowers patients to support their pharmacotherapy, including disease-modifying antirheumatic drugs (DMARDs), leading to better long-term outcomes.
- Nutritional therapy benefits become apparent after three months, intensifying within twelve months, and can lead to a reduction in NSAID and glucocorticoid dosages by an average of one-third.
Impact:
- Early integration of dietary counseling with DMARD therapy can optimize treatment efficacy.
- Nutritional interventions may reduce the reliance on and dosage of medications like NSAIDs and glucocorticoids.
- Improved patient outcomes and quality of life are achievable through a combined approach of pharmacotherapy and tailored nutritional support.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...